ClinicalTrials.Veeva

Menu

Misoprostol for the Prevention of Postpartum Hemorrhage in Rural Pakistan

G

Gynuity Health Projects

Status

Completed

Conditions

Anemia
Postpartum Hemorrhage

Treatments

Drug: Misoprostol

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

This community-based trial will study misoprostol for the prevention of postpartum hemorrhage in rural Pakistan. Traditional birth attendants assisting home deliveries will administer study tablets (600 mcg oral misoprostol or placebo) in the third stage of labor to women participating in the trial. Blood loss, hemoglobin levels, side effects, and other variables will be evaluated.

Enrollment

1,600 patients

Sex

Female

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Pregnant women in general good health, home delivery
  • Must live in one of 78 study villages

Exclusion criteria

  • Hypertension
  • Non-cephalic presentation
  • Polyhydramnios
  • Previous cesarean section
  • Suspected multiple pregnancy
  • Suspected still birth
  • Antepartum hemorrhage
  • Previous complication in 3rd trimester
  • Anemia of <8 g/dl

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems